Thus, we performed a CD8+ T cell-mediated cancer cell killing assay to confirm that TEM treatment can increase the CD8+ T cell-mediated anti-cancer effect by inhibiting the secretion of sEV PD-L1. The gene discussed is CD274; the disease is cancer.